Follow
farzin rezaei
farzin rezaei
Verified email at muk.ac.ir
Title
Cited by
Cited by
Year
Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia
S Akhondzadeh, F Rezaei, B Larijani, AA Nejatisafa, L Kashani, ...
Schizophrenia research 84 (2-3), 405-410, 2006
1862006
N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
M Farokhnia, A Azarkolah, F Adinehfar, MR Khodaie-Ardakani, ...
Clinical neuropharmacology 36 (6), 185-192, 2013
1382013
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia
A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ...
CNS drugs 27 (1), 57-65, 2013
1132013
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania
Z Amrollahi, F Rezaei, B Salehi, AH Modabbernia, A Maroufi, ...
Journal of affective disorders 129 (1-3), 327-331, 2011
1072011
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study
MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ...
Psychiatry Research 215 (3), 540-546, 2014
992014
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial
SH Abbasi, H Behpournia, A Ghoreshi, B Salehi, M Raznahan, ...
Schizophrenia research 116 (2-3), 101-106, 2010
902010
Efficient or opportunistic earnings management with regards to the role of firm size and corporate governance practices
F Rezaei, M ROSHAN
INTERDISCIPLINARY JOURNAL OF CONTEMPORARY RESEARCH IN BUSINESS 3 (9), 1312-1322, 2012
712012
Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study
F Rezaei, M Mohammad-Karimi, S Seddighi, A Modabbernia, M Ashrafi, ...
Journal of clinical psychopharmacology 33 (3), 336-342, 2013
692013
Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial
S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ...
Bipolar disorders 17 (6), 606-614, 2015
682015
Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
S Akhondzadeh, R Ghayyoumi, F Rezaei, B Salehi, AH Modabbernia, ...
Psychopharmacology 213 (4), 809-815, 2011
462011
A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders
E Hasanzadeh, MR Mohammadi, A Ghanizadeh, SA Rezazadeh, ...
Child Psychiatry & Human Development 43 (5), 674-682, 2012
452012
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
G Kianimehr, F Fatehi, S Hashempoor, MR Khodaei-Ardakani, F Rezaei, ...
DARU Journal of Pharmaceutical Sciences 22 (1), 1-7, 2014
432014
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial
AR Zarinara, MR Mohammadi, N Hazrati, M Tabrizi, SA Rezazadeh, ...
Human Psychopharmacology: Clinical and Experimental 25 (7‐8), 530-535, 2010
432010
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia
M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ...
Psychopharmacology 228 (4), 595-602, 2013
402013
Comparison of self-esteem, locus of control and their relationship with university students’ educational status at Shahid Sadoughi University of Medical Sciences-Yazd
M Mirzaei Alavijeh, N Rajaei, F Rezaei, S Hasanpoor, R Pirouzeh, ...
The Journal of Medical Education and Development 7 (1), 58-70, 2012
402012
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
M Farokhnia, M Sabzabadi, H Pourmahmoud, MR Khodaie-Ardakani, ...
Psychopharmacology 231 (3), 533-542, 2014
382014
Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial
F Rezaei, M Emami, S Zahed, MJ Morabbi, M Farahzadi, S Akhondzadeh
DARU Journal of Pharmaceutical Sciences 23 (1), 1-8, 2015
362015
A SURVEY OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES STUDENTS'OPINIONS ABOUT RESEARCH BARRIERS DURING UNIVERSITY TRAINING
MSS MAZLOOMY, SP Hosseini, SM ABBASI, AM MIRZAEI, F Rezaei
JOURNAL OF MEDICAL EDUCATION DEVELOPMENT 6 (10), 63-70, 2013
342013
Topiramate for the management of methamphetamine dependence: a pilot randomized, double‐blind, placebo‐controlled trial
F Rezaei, E Ghaderi, R Mardani, S Hamidi, K Hassanzadeh
Fundamental & clinical pharmacology 30 (3), 282-289, 2016
292016
L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial
A Zeinoddini, M Ahadi, M Farokhnia, F Rezaei, M Tabrizi, S Akhondzadeh
Journal of psychiatric research 59, 125-131, 2014
292014
The system can't perform the operation now. Try again later.
Articles 1–20